Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 42


Depression and health-related quality of life in chronic obstructive pulmonary disease.

Omachi TA, Katz PP, Yelin EH, Gregorich SE, Iribarren C, Blanc PD, Eisner MD.

Am J Med. 2009 Aug;122(8):778.e9-15. doi: 10.1016/j.amjmed.2009.01.036.


Chronic obstructive pulmonary disease, anxiety, and depression: state of the science.

Putman-Casdorph H, McCrone S.

Heart Lung. 2009 Jan-Feb;38(1):34-47. doi: 10.1016/j.hrtlng.2008.02.005. Review.


BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study.

Funk GC, Kirchheiner K, Burghuber OC, Hartl S.

Respir Res. 2009 Jan 9;10:1. doi: 10.1186/1465-9921-10-1.


Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA; ACCP Workshop Panel on Anxiety and Depression in COPD.

Chest. 2008 Oct;134(4 Suppl):43S-56S. doi: 10.1378/chest.08-0342. Review.


A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.


Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.

Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, Wang C, Bourbeau J.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):913-20. doi: 10.1164/rccm.200804-619OC. Epub 2008 Aug 28.


COPD as a systemic disease: impact on physical functional limitations.

Eisner MD, Blanc PD, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Iribarren C.

Am J Med. 2008 Sep;121(9):789-96. doi: 10.1016/j.amjmed.2008.04.030.


Occupational exposures and the risk of COPD: dusty trades revisited.

Blanc PD, Iribarren C, Trupin L, Earnest G, Katz PP, Balmes J, Sidney S, Eisner MD.

Thorax. 2009 Jan;64(1):6-12. doi: 10.1136/thx.2008.099390. Epub 2008 Aug 4.


The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease.

Puhan MA, Frey M, Büchi S, Schünemann HJ.

Health Qual Life Outcomes. 2008 Jul 2;6:46. doi: 10.1186/1477-7525-6-46.


Longitudinal change in the BODE index predicts mortality in severe emphysema.

Martinez FJ, Han MK, Andrei AC, Wise R, Murray S, Curtis JL, Sternberg A, Criner G, Gay SE, Reilly J, Make B, Ries AL, Sciurba F, Weinmann G, Mosenifar Z, DeCamp M, Fishman AP, Celli BR; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):491-9. doi: 10.1164/rccm.200709-1383OC. Epub 2008 Jun 5.


Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.

Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. doi: 10.1164/rccm.200712-1869OC. Epub 2008 May 29.


Nicotine dependence and mental disorders among adults in the USA: evaluating the role of the mode of administration.

Goodwin RD, Zvolensky MJ, Keyes KM.

Psychol Med. 2008 Sep;38(9):1277-86. doi: 10.1017/S0033291708003012. Epub 2008 Mar 26.


Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.

Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Blanc PD.

Am J Epidemiol. 2008 May 1;167(9):1090-101. doi: 10.1093/aje/kwn025. Epub 2008 Mar 14.


Anxiety and depression in end-stage COPD.

Hill K, Geist R, Goldstein RS, Lacasse Y.

Eur Respir J. 2008 Mar;31(3):667-77. doi: 10.1183/09031936.00125707. Review.


Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.

Thorax. 2008 Jul;63(7):592-8. doi: 10.1136/thx.2007.087213. Epub 2008 Feb 1.


The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.


International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group.

Lancet. 2007 Sep 1;370(9589):741-50. Erratum in: Lancet. 2012 Sep 1;380(9844):806.


The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease.

Pérez-Padilla R, Vázquez-García JC, Márquez MN, Jardim JR, Pertuzé J, Lisboa C, Muiño A, López MV, Tálamo C, de Oca MM, Valdivia G, Menezes AM; Latin American COPD Prevalence Study (PLATINO) Team.

Respir Care. 2006 Oct;51(10):1167-71.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk